ARTHUR J. KLAUSNER - 01 Feb 2023 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Director
Signature
/s/ Kim R. Tsuchimoto, Attorney-in-fact
Issuer symbol
MNPR
Transactions as of
01 Feb 2023
Transactions value $
$0
Form type
4
Filing time
03 Feb 2023, 17:47:49 UTC
Previous filing
03 Jan 2023
Next filing
04 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Stock Options Award $0 +13,930 $0.000000 13,930 01 Feb 2023 Common Stock 13,930 $3.16 Direct F1
transaction MNPR Restricted Stock Units Award $0 +10,133 $0.000000 10,133 01 Feb 2023 Common Stock 10,133 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest 25% quarterly on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.
F2 RSUs vest 25% quarterly on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.